Page last updated: 2024-09-02

morpholinoanthracycline mx2 and amrubicin

morpholinoanthracycline mx2 has been researched along with amrubicin in 3 studies

Compound Research Comparison

Studies (morpholinoanthracycline mx2)	Trials (morpholinoanthracycline mx2)	Recent Studies (post-2010) (morpholinoanthracycline mx2)	Studies (amrubicin)	Trials (amrubicin)	Recent Studies (post-2010) (amrubicin)
53	15	0	230	76	112

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	2 (66.67)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kimura, I; Kiura, K; Ohnoshi, T; Takigawa, N; Ueoka, H	1
Bungo, M; Fujiwara, Y; Fukuda, M; Horichi, N; Minato, K; Nakagawa, K; Niimi, S; Ohe, Y; Saijo, N; Sasaki, Y	1
Ariyoshi, Y; Ogawa, M	1

Reviews

1 review(s) available for morpholinoanthracycline mx2 and amrubicin

Article	Year
[New anthracyclines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1 Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms	1993

Trials

1 trial(s) available for morpholinoanthracycline mx2 and amrubicin

Article	Year
[New anthracyclines]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:1 Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Carubicin; Doxorubicin; Humans; Idarubicin; Leukemia, Experimental; Leukemia, Myeloid, Acute; Menogaril; Stomach Neoplasms	1993

Other Studies

2 other study(ies) available for morpholinoanthracycline mx2 and amrubicin

Article	Year
Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines. Acta medica Okayama, 1992, Volume: 46, Issue:4 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Carubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Structure; Tumor Cells, Cultured	1992
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines. Cancer research, 1989, Aug-01, Volume: 49, Issue:15 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured	1989

Article

Year

Comparison of antitumor activity of new anthracycline analogues, ME2303, KRN8602, and SM5887 using human lung cancer cell lines.

Acta medica Okayama, 1992, Volume: 46, Issue:4

Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Carubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Molecular Structure; Tumor Cells, Cultured

1992

In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Cancer research, 1989, Aug-01, Volume: 49, Issue:15

Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Carubicin; Cisplatin; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Menogaril; Mitomycins; Nogalamycin; Tumor Cells, Cultured

1989